1. Zhang, Yi, Li, Qin-Shan, Liu, Hong-Lin, Liu, Li-Hong, Li, Meng-Xing. 2023. MKRN1 promotes colorectal cancer metastasis by activating the TGF-β signalling pathway through SNIP1 protein degradation. In Journal of experimental & clinical cancer research : CR, 42, 219. doi:10.1186/s13046-023-02788-w. https://pubmed.ncbi.nlm.nih.gov/37620897/
2. Deng, Ling, Liao, Li, Zhang, Yin-Ling, Shao, Zhi-Ming, Li, Da-Qiang. 2024. SF3A2 promotes progression and cisplatin resistance in triple-negative breast cancer via alternative splicing of MKRN1. In Science advances, 10, eadj4009. doi:10.1126/sciadv.adj4009. https://pubmed.ncbi.nlm.nih.gov/38569025/
3. Wang, Tongtong, Liu, Wenqiang, Wang, Changfa, Li, Yubao, Li, Liangliang. 2022. MRKNs: Gene, Functions, and Role in Disease and Infection. In Frontiers in oncology, 12, 862206. doi:10.3389/fonc.2022.862206. https://pubmed.ncbi.nlm.nih.gov/35463379/
4. Cassar, Paul A, Carpenedo, Richard L, Samavarchi-Tehrani, Payman, Gibbings, Derrick, Stanford, William L. 2015. Integrative genomics positions MKRN1 as a novel ribonucleoprotein within the embryonic stem cell gene regulatory network. In EMBO reports, 16, 1334-57. doi:10.15252/embr.201540974. https://pubmed.ncbi.nlm.nih.gov/26265008/
5. Dong, Xiang, Zhan, Yuling, Li, Suwan, Yang, Minghui, Gao, Yu. 2024. MKRN1 regulates the expression profiles and transcription factor activity in HeLa cells inhibition suppresses cervical cancer cell progression. In Scientific reports, 14, 6129. doi:10.1038/s41598-024-56830-8. https://pubmed.ncbi.nlm.nih.gov/38480859/
智鼠故事 
